Radford S A, Johnson E M, Warnock D W
Mycology Reference Laboratory, Public Health Laboratory, Bristol, United Kingdom.
Antimicrob Agents Chemother. 1997 Apr;41(4):841-3. doi: 10.1128/AAC.41.4.841.
The in vitro activity of voriconazole was compared with that of itraconazole. Eighty-six isolates of pathogenic molds belonging to 23 species were tested by an agar dilution method in High Resolution medium. Voriconazole was more active than itraconazole against a number of hyaline molds, including several Fusarium spp. and Scedosporium prolificans. Voriconazole and itraconazole showed comparable good activity against several hyaline molds, including Penicillium marneffei and Scedosporium apiospermum, and a number of dematiaceous molds, including Bipolaris australiensis, Cladophialophora bantiana, several Exophiala spp., and several Fonsecaea spp. Our results suggest that voriconazole could be effective against a wide range of mold infections in humans.
将伏立康唑的体外活性与伊曲康唑进行了比较。采用琼脂稀释法在高分辨率培养基中对属于23个种的86株致病霉菌进行了检测。伏立康唑对多种透明霉菌，包括几种镰刀菌属和多育赛多孢，比伊曲康唑更具活性。伏立康唑和伊曲康唑对几种透明霉菌，包括马尔尼菲青霉和尖端赛多孢，以及多种暗色霉菌，包括澳大利亚离蠕孢、班替枝孢瓶霉、几种外瓶霉属和几种瓶霉属，显示出相当的良好活性。我们的结果表明，伏立康唑可能对人类多种霉菌感染有效。
